SYNTAX
LIVE

Serial Number

79363759

Owner

DNA SCRIPT

Attorney

Bryce J. Maynard

Filing Date

Jul 20, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SYNTAX Trademark

Serial Number: 79363759 • Registration: 8016638

SYNTAX is a trademark filed by DNA SCRIPT on July 20, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

DNA SCRIPT (9 trademarks)

67 avenue de Fontainebleau

Entity Type: 34

Trademark Details

Filing Date

July 20, 2022

Registration Date

November 11, 2025

Published for Opposition

September 23, 2025

Goods & Services

Apparatus and instruments for laboratory and scientific use for polynucleotide synthesis in the field of DNA and RNA, namely, pipetors, liquid handlers, laboratory columns for chemical synthesis, scientific apparatus and instruments for measuring relative DNA, RNA and protein, laboratory research instruments for DNA analysis, as well as parts and accessories for such apparatus and instruments, namely, laboratory glassware in the nature of bottles, flasks, cartridges, vials, reaction plates, synthesis supports, and reaction tubes, as well as computer hardware and downloadable computer software relating thereto for use in operating and interfacing with apparatus and instruments for synthesizing polynucleotides; apparatus and instruments for laboratory and scientific use in using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems, namely, laboratory devices for detecting genetic sequences, scientific apparatus and instruments for measuring relative DNA, RNA and protein, electrical equipment for the genetic modification of cells for research purposes, laboratory apparatus and instruments for extracting nucleic acid; DNA chips; Apparatus for scientific use for preservation, storage or processing of DNA chips containing information, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein, laboratory apparatus and instruments for extracting nucleic acid; computer hardware and recorded and downloadable computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and recorded and downloadable computer software for polynucleotide synthesis, namely, DNA and RNA; computer hardware and recorded and downloadable computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and recorded and downloadable computer software for use in preserving, storing or processing DNA chips containing information; biochips for scientific research purposes and data storage purposes; all the aforesaid goods other than those directly for use in the cardiovascular field

Chemicals, reagents, enzymes, and kits comprising enzymes, nucleotide monomers, solid phase synthesis media, and synthesis plates for laboratory use, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in the course of scientific research conducted in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical preparations for analyses in laboratories other than for medical or veterinary use; protein in raw material form for scientific research; all the aforesaid goods other than those directly for use in the cardiovascular field

Medical services; veterinary services; cosmetic and medical skin care services for beauty and sanitary care purposes; medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and treatment purposes; advice with respect to health in the field of DNA and its preservation; consultation with respect to pharmaceuticals; all the aforesaid services other than those directly for use in the cardiovascular field

Technical research in the field of polynucleotide synthesis; biological research; chemical research; medical research; chemical analysis; chemistry services, namely, research and laboratory analysis in the field of chemistry; scientific laboratory services; designing and testing synthetic DNA for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA synthesis for scientific research purposes; computer services for storing nucleic acid molecules, particularly, cloud storage services for electronic data comprising visual representations of nucleic acid molecules for use in amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of cells, samples or biological systems on DNA chips containing information; biological research laboratory services in the field of nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of cells, samples or biological systems on DNA chips containing information; chemical laboratory services in the field of nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of cells, samples or biological systems on DNA chips containing information; scientific research and laboratory services in the field of nucleic acid molecules, particularly for the amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of cells, samples or biological systems on DNA chips containing information; computer services for the preservation, storage or processing of data on DNA chips containing information, namely, providing temporary use of online non-downloadable computer software for preserving, storing and processing data in the field of DNA; biological research laboratory services for preservation or processing of data on DNA chips containing information; chemical laboratory services for preservation or processing of data on DNA chips containing information; scientific research and laboratory services for the preservation or processing of data on DNA chips containing information; technical research in the field of DNA and RNA, namely, conducting of technical project studies; software development and design; software rental, namely, rental of computer software for operating apparatus and instruments for DNA and RNA synthesis; digitization of documents; Software as a Service (SaaS) featuring software for operating apparatus and instruments for DNA and RNA synthesis; cloud computing featuring software for operating apparatus and instruments for DNA and RNA synthesis; graphic arts design services; styling being industrial design services; authentication of works of art; energy auditing; all the aforesaid services other than those directly for use in the cardiovascular field

Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification, and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use; all the aforesaid goods other than those directly for use in the cardiovascular field

DNA and RNA testing apparatus for medical use; DNA sample testing apparatus for medical use; diagnostic apparatus for medical use for the detection of genetic particularities, mutations and diseases; analysis devices for identification of bacteria for medical use; all the aforesaid goods other than those directly for use in the cardiovascular field

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 11, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 17, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 20, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 20, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 20, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 20, 2025 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 31, 2025 RCCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 11, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 22, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 21, 2024 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 16, 2024 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 15, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 15, 2023 GNSL
SUSPENSION LETTER WRITTEN
Nov 15, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 30, 2023 TROA
REFUSAL PROCESSED BY IB
May 31, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 11, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 11, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 21, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 20, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 3, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 24, 2023 REPR